APOTHEEK DE VRIESE G.
ActiveSummary
APOTHEEK DE VRIESE G. has been active since 1986 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €205k and a net result of €38k. Equity remains stable across the filed fiscal years (±1.1% per year). Its solvency ranks better than 49% of 9623 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.5% (low).
Checked score
Score 2024
67
/ 100
Healthy
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability78▲+2
Solvency63▼-1
Growth58=
Track record100
Bankruptcy probability, 12 months
0.5%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €13k at 30 days acceptable
Liquidity ample (current ratio 1.53 against 1.71 in 2023; short-term debt: 47.7% and cash: 13.1% of total assets), but 62.1% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Three signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 29-08-2025, 29 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
29 d late
2023
30 d late
2022
63 d late
2021
31 d late
2020
31 d late
2019
81 d late
← before the deadline
after the deadline →
Checked, nothing found (1)
Financials · fiscal year 2024, abbreviated schema
Equity
€205k=
2023 · €205k
2018: €224k
2019: €217k
2020: €205k
2021: €205k
2022: €205k
2023: €205k
2018 → 2024
Total assets
€542k▲ 3.2%
2023 · €525k
2018: €444k
2019: €469k
2020: €490k
2021: €519k
2022: €523k
2023: €525k
2018 → 2024
Net result
€38k▲ 20.3%
2023 · €32k
2018: €3k
2019: €17k
2020: €34k
2021: €24k
2022: €24k
2023: €32k
2018 → 2024
Working capital
€136k▼ 16.2%
2023 · €162k
2018: €206k
2019: €199k
2020: €185k
2021: €178k
2022: €178k
2023: €162k
2018 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220232024Trend
Equity€205k-€205k=€205k=€205k=€205k=
Operating result€45k-€32k▼ 27.6%€35k▲ 9.5%€44k▲ 23.5%€48k▲ 9.7%
Net result€34k-€24k▼ 28.7%€24k▼ 1.2%€32k▲ 34.2%€38k▲ 20.3%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2021 the operating result has climbed three years in a row; 2024 is 10% above 2023 and is the highest result in the available series.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €542k
Fixed assets
€148k ▲ 10.6%
Current assets
€394k ▲ 0.7%
Equity and liabilities €542k
Equity
€205k =
Debt
€337k ▲ 5.3%
Debt's share of the balance-sheet total rises from 60.9% to 62.1%. Debt is higher.
Key figures and ratios
EBITDA
€61k▲
2023 · €53k
Cash flow
€51k▲
2023 · €41k
Current ratio
1.53▼
2023 · 1.71
Quick ratio
0.90▼
2023 · 1.01
Debt to equity
1.64▲
2023 · 1.56
ROE
18.6%▲
2023 · 15.5%
ROA
7.1%▲
2023 · 6.0%
Interest coverage
26.13▲
2023 · 21.29
Debt ≤ 1 year
€258k▲
2023 · €229k
Debt > 1 year
€78k▼
2023 · €87k
Income taxes
€12k▲
2023 · €11k
Staff costs
€116k▲
2023 · €115k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2024 against 2023 · 54 lines
Balance sheet
Code20232024
Assets
Total assets20/58€525k€542k▲
Fixed assets21/28€134k€148k▲
Tangible fixed assets22/27€134k€148k▲
Land and buildings22€117k€117k▲
Plant, machinery and equipment23€2k€2k▼
Furniture and vehicles24€15k€29k▲
Financial fixed assets28€80€80=
Current assets29/58€391k€394k▲
Stocks and contracts in progress3€159k€162k▲
Stocks30/36€159k€162k▲
Amounts receivable within one year40/41€143k€153k▲
Trade receivables40€108k€93k▼
Other amounts receivable41€35k€61k▲
Current investments50/53-€5k
Cash at bank and in hand54/58€85k€71k▼
Deferred charges and accrued income490/1€4k€3k▼
Equity and liabilities
Total equity and liabilities10/49€525k€542k▲
Equity10/15€205k€205k=
Contributions10/11€19k€19k=
Reserves13€187k€187k=
Non-distributable reserves130/1€2k€2k=
Reserves not available under the articles1311€2k€2k=
Distributable reserves133€185k€185k=
Amounts payable17/49€320k€337k▲
Amounts payable after more than one year17€87k€78k▼
Financial debts170/4€87k€78k▼
Amounts payable within one year42/48€229k€258k▲
Current portion of amounts payable after more than one year42€12k€13k▲
Trade debts44€168k€182k▲
Suppliers440/4€168k€182k▲
Taxes, remuneration and social security45€16k€25k▲
Taxes450/3€5k€4k▼
Remuneration and social security454/9€11k€21k▲
Other amounts payable47/48€33k€39k▲
Accrued charges and deferred income492/3€4k€763▼
Income statement
Code20232024
Remuneration, social security and pensions62€115k€116k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€9k€13k▲
Other operating charges640/8€2k€2k▼
Gross operating margin9900€170k€179k▲
Operating profit (loss)9901€44k€48k▲
Financial income75/76B€2k€5k▲
Recurring financial income75€2k€2k▼
Non-recurring financial income76B-€3k
Financial charges65/66B€2k€2k▼
Recurring financial charges65€2k€2k▼
Profit (loss) for the period before taxes9903€43k€51k▲
Income taxes67/77€11k€12k▲
Profit (loss) for the period9904€32k€38k▲
Profit (loss) for the period to be appropriated9905€32k€38k▲
Appropriation of the result
Profit (loss) to be appropriated9906€32k€38k▲
Profit to be distributed694/7€32k€38k▲
Return on contributions (dividend)694€1k€1k▲
Directors or managers695€31k€37k▲
Social balance
Average headcount (FTE)90871.51.5=
The notes to these accounts (14 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
29-08
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema · 29 days late
2024
31-12
Financial
Highest result since 2018net €38k ▲20.3%
Operating result €48k, net result €38k, both a record.
30-08
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema · 30 days late
2023
02-10
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema · 63 days late
2022
31-08
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema · 31 days late
2021
31-08
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema · 31 days late
2020
20-10
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema · 81 days late
2019
30-08
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema · 30 days late
2018
19-07
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
31-08
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema · 31 days late
2016
31-08
NBB filing
Annual accounts filed
fiscal year 2015 · abbreviated schema · 31 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Lokeren · 1 establishment unit since 1987
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Heiendestraat 119160 LokerenGround area
1,298 m²
Building footprint
272 m²
Volume, LiDAR
1,552 m³
Parcel 46384C0701/00R002, Flanders · tallest building 11.5 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
APOTHEEK DE VRIESE G
since 19872.034.219.860
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 46384C0701/00R002 | Flanders | 1,298 m² | 1 · 272 m² | 11.5 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
PHARMACIE BAUDOUX M.C.
BE 0455.633.249
Gerpinnes · Eq €205,617
BAUPHAR
BE 0878.246.017
Rebecq · Eq €205,623
APOTHEEK STEEVENS
BE 0889.161.683
Blankenberge · Eq €205,291
APOTHEEK OPLINTER
BE 0841.745.214
Tienen · Eq €205,813
SIBILIA
BE 0537.764.337
Grimbergen · Eq €205,895
Of 5,220 companies in sector 47730 we hold annual accounts for 3,861. 3,560 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded30-12-1986
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
Sources
Crossroads Bank for EnterprisesNational Bank · 38 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.